Abstract
72. 6. Harbeck N, Jakesz, R. St. Gallen 2007: Breast Cancer Treatment Consensus Report. Breast Care 2007;2:130–4. 7. Sledge GW, O’Neill A, Thor A, et al. Adjuvant trastuzumab: long-term results of E2198. Breast Cancer Res Treat 2006;100:S106. 8. Norris B, Chia S, Cheang M, et al. Poor 10yr breast cancer specific survival (BCSS) and relapse free survival (RFS) for HER-2 positive T1pN0 tumors. San Antonio Breast Cancer Conference 2006; Poster 2031. 9. Joensuu H, Isola J, Lundin M, et al. Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study. Clin Cancer Res
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
